Searched for
RISPERIDONE
Overweight on Lupin, target price Rs 2,600: Axis SecuritiesAxis Securities recommends an overweight call on Lupin with a target price of Rs 2600. Lupin's current price is Rs 2160. New launches in th...15 Jan, 2025, 08.51 AM IST- USFDA issues import alert on Jubilant Pharmova's Roorkee plantThe US Food and Drug Administration (USFDA) has taken the action after conducting an inspection of the formulations plant in March this yea...15 Jul, 2021, 05.15 PM IST
- Lupin, Cadila recall drugs in US MarketZydus Pharmaceuticals USA Inc, arm of Cadila Healthcare, is also recalling 19,812 bottles of Paroxetine tablets in the strength of 30 mg fr...07 Dec, 2017, 11.34 PM IST
- Lupin, Cadila Healthcare recall drugs in USZydus Pharmaceuticals USA Inc, arm of Cadila Healthcare, is also recalling 19,812 bottles of Paroxetine tablets in the strength of 30 mg fr...07 Dec, 2017, 04.50 PM IST
- Zydus Pharma recalls 44.8 K bottles of antidepressant in USThe reason for recall is presence of foreign tablets. "Risperidone tablets were found in bottle of paroxetine tablets", the report said.21 Sep, 2017, 03.56 PM IST
- Zydus Pharma Inc recalls 9,504 bottles of Risperidone tabletsRisperidone tablets are used in the treatment of schizophrenia. "The reason for recall is "out of specification for a known degradant," it ...07 Mar, 2016, 04.45 PM IST
- Aurobindo receives Australia nod for schizophrenia, osteoporosis drugsAurobindo Pharma has received approval from the Australian health authority to market Risperidone and Alendronate tablets.17 May, 2011, 02.25 PM IST
- Aurobindo gets USFDA approval for Risperidone Oral SolutionDrug firm Aurobindo Pharma today said it has received US regulatory approval for its Risperidone Oral Solution used in the treatment of men...07 Sep, 2009, 01.08 PM IST
- Zydus, Teva end patent disputesAhmedabad-based ZydusCadila and Israeli generic major Teva have settled their patent disputes over active pharmaceutical ingredients (APIs)...02 Jun, 2009, 01.44 AM IST
- Aussie nod for Ranbaxy's anti-psychotic drugRanbaxy Laboratories has received the Australian drug regulator’s nod to sell its generic version of drugmaker Janssen-Cilag's anti-schizop...26 Mar, 2009, 02.45 AM IST
- Ranbaxy gets Australia nod for antipsychotic drugRanbaxy Laboratories has received the Australian drug regulator’s nod to sell its generic version of drugmaker Janssen-Cilag’s anti-schizop...25 Mar, 2009, 04.04 PM IST
- Aurobindo Pharma surges 13% on USFDA nodShares of Aurobindo Pharma extended gains after the company received US administration's approval for Sertraline Hydrochloride oral concent...10 Nov, 2008, 10.58 AM IST
- Stocks to watch: SBI, Reliance, Zydus CadillaEquities are likely to open lower on Monday following meltdown in overseas markets on fears of slow-down in global economy and recession in...27 Oct, 2008, 09.49 AM IST
- Zydus drags Teva to court for antitrust violationsZydus Cadila, an Ahmedabad-based pharmaceutical company, has taken Teva Pharmaceuticals, the world’s largest generic drug maker, to court i...27 Oct, 2008, 12.00 AM IST
- Lupin's Japanese arm gets nod for 10 productsLupin's Japanese subsidiary Kyowa Pharma has received approvals for 10 products and expects to launch these in July 2008 post NHI listing.23 Apr, 2008, 05.07 PM IST
- Ranbaxy got USFDA nod for RisperdalThe country's largest drugmaker Ranbaxy Laboratories received the US food and drug administration (USFDA) nod to sell generic version of Ri...04 Mar, 2008, 06.43 PM IST
- Ranbaxy to market second licensed generic in CanadaThe generic fentanyl patch is sold under Ranbaxy's label 'Ran Fentanyl Transdermal System', used for management of persistent and chronic p...06 Oct, 2006, 02.53 PM IST
Load More
